Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Clinical trial NCT03574597 · COMPLETED
Trial details
- NCT number
- NCT03574597
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-24
- Primary completion
- 2023-06-21
- Enrollment
- 17604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.